Bromocriptine Mesylate Tablet
Product Images NDC 70954-978

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 70954-978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container One (Container One)

Each tablet of this medication contains 2.5 mg of Bromocriptine (as the mesylate). It is advised to refer to the package insert for dosage information. Store this medication at 68°F to 77°F (20°C to 25°C) with excursions permitted to 59°F to 86°F (15°C to 30°C). Ensure it is stored in a tight, light-resistant container and keep it out of the reach of children. Distributed by ANI Pharmaceuticals, Inc. and manufactured by Esjay Pharma Private Limited. This medication is only available with a prescription.*

FDA Label Image

Container Two (Container Two)

This is a description of Bromocriptine Mesylate tablets, USP, which are prescription medicine containing 2.5 mg of Bromocriptine. The package contains 100 tablets with dosage information provided in the package insert. The medicine should be stored at 68°F to 77°F (20°C to 25°C) with excursions permitted to 59°F to 86°F (15°C to 30°C). It should be dispensed in a tight, light-resistant container and kept out of reach of children. The tablets are distributed by ANI Pharmaceuticals, Inc., Baudette, MN 56623, and manufactured by Esjay Pharma Private Limited, India.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.